38th Pharmacovigilance USA 2025 addresses the challenges and opportunities in pharmacovigilance, focusing on patient safety, technology impact, regulatory aspects, and trends in the industry.
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.